 Effects thromboxane synthesis inhibitor triflusal renal hemodynamics microalbuminuric diabetic patients Triflusal acid platelet-antiaggregant drug thromboxane synthesis little effect prostacyclin production study effect administration mg/day triflusal glomerular filtration rate GFR renal plasma flow RPF urinary albumin excretion UAE thromboxane alpha normotensive insulin-dependent diabetic patients UAE micrograms/min Plasma plasma renin activity PRA administration triflusal reduction microalbuminuria micrograms/min increase RPF reduction filtration fraction Triflusal significant reduction plasma pg/ml urine pg/min changes PRA UAE alpha Metabolic control arterial blood pressure change study results platelet-antiaggregant therapy microalbuminuria diabetic patients effect reduction transglomerular hydraulic pressure vasodilation efferent arterioles secondary thromboxane synthesis inhibition